Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...

Jan. 29, 2025 — Researchers have identified priority areas for conserving the black-tailed prairie dog in the United States. Protecting these regions will also benefit North America's Central ...

After hours: January 31 at 6:55:47 PM EST Loading Chart for PHGE ...